Fentanyl Infusion Solution Recalled for Lack of Sterility Assurance
Family Pharmacy of Statesville is recalling one lot of Fentanyl 150 mcg/mL Infusion Solution in 250 mL bags because the manufacturer cannot assure the product's sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterility defect in an injectable opioid medication. Loss of sterility assurance in intravenous drugs poses significant risk of infection and serious patient harm, meeting the Severe category threshold.
Plain-English summary
Family Pharmacy of Statesville, Inc. is recalling Fentanyl 150 mcg/mL Infusion Solution in 250 mL bags, Lot #07312020@5 with a BUD of 8/14/2020, distributed in North Carolina only.
The recall was issued because the manufacturer cannot provide assurance that the product maintains sterility. Fentanyl infusion solutions must be sterile for safe intravenous use.
Patients receiving this medication should contact their healthcare provider or pharmacy immediately. Healthcare providers should not dispense or administer product from the recalled lot. Unused product should be returned to the pharmacy for proper disposal.
The recalled product
- Product
- Fentanyl 150 mcg/mL Infusion Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.
- Manufacturer
- Family Pharmacy of Statesville
- Hazard
- sterility-failure
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 07312020@5 BUD: 8/14/2020
Distribution
Distributed in 1 state:
- NC
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27